Three national patent offices have consulted on patents that cover protein three-dimensional structural data and pharmacophores, with significant implications for the biotechnology industry.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Trilateral Project WM4, Comparative Studies in New Technologies. Report on Comparative Study on Protein 3-Dimensional Structure Related Claims, Vienna, Austria, November 4–8, 2002.
Flower, R.J. The development of Cox2 inhibitors. Nature Rev. Drug Discov. 2, 179–191 (2003).
Hultquist, S.J. et al. Patenting bioinformatic inventions: emerging trends in Europe, Nat. Biotechnol. 20, 517–518 (2002).
Hultquist, S.J. et al. Patenting bioinformatic inventions: emerging trends in the United States, Nat. Biotechnol. 20, 743–744 (2002).
USPTO. Examination guidelines for computer-related inventions, 61 Fed. Reg. 7478 (1996).
In re Lowry, 32 F.3d 1579, 1583-4, 32 USPQ2d 1031, 1035 (Fed. Cir. 1994).
In re Warmerdam, 33 F.3d 1354, 1316, 31USPQ2d 1754, 1760 (Fed. Cir. 1994).
T 1173/97 (OJ 1999, 609).
JPO. Examination guidelines for patent and utility model in Japan, Part VII, Chapter 1 (2001).
State Street Bank & Trust Co. vs. Signature Fin. Group, Inc., 149 F.3d 1368, 47 USPQ 2d 1596 (Fed. Cir. 1998).
Formulating and communication rejections under 35 USC 103 for applications directed to computer-implemented business method inventions, IV. A. Example 12: Rationale reasoned from the difference is the data being stored (2000).
Case of an herbicidal imidazole derivative, Tokyo High Court, 1990 (Gyo Ke), Decision No. 243 (H6.3.22). As comparable case, Case of natriuretic peptide Tokyo High Court, 1998 (Gyo Ke), Decision No. 393 (H13.3.15).
EPO. Guidelines for examination in the EPO, Part C, Chapter III, 4.7a, June 2000.
Case of a muscarine-like receptor antagonist, Tokyo High Court, 2001 (Gyo Ke), Decision No. 345 (H14.10.1). As comparable case, Case of antimetic drug, Tokyo High Court, 1996 (Gyo Ke), Decision No. 201 (H10.10.30).
Acknowledgements
We thank Sheryl R. Silverstein, Takayuki Hirose, Toshio Miyake, and Cora Tsang for advice on the article. This work was supported in part by the RIKEN StructuralGenomics/Proteomics Initiative (RSGI), the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimbo, I., Nakajima, R., Yokoyama, S. et al. Patent protection for protein structure analysis. Nat Biotechnol 22, 109–112 (2004). https://doi.org/10.1038/nbt0104-109
Issue Date:
DOI: https://doi.org/10.1038/nbt0104-109